Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody.

Fifty-two patients with epithelial ovarian cancer were treated with yttrium-90-labelled monoclonal antibody HMFG1 administered intraperitoneally following conventional surgery and chemotherapy as part of an extended phase I-II trial. The treatment was well tolerated and the only significant toxicity...

Descripción completa

Detalles Bibliográficos
Autores principales: Hird, V., Maraveyas, A., Snook, D., Dhokia, B., Soutter, W. P., Meares, C., Stewart, J. S., Mason, P., Lambert, H. E., Epenetos, A. A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968585/
https://www.ncbi.nlm.nih.gov/pubmed/8347497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968585/
https://www.ncbi.nlm.nih.gov/pubmed/8347497

Ejemplares similares